Axsome begins Phase III AXS-14 FORWARD trial for fibromyalgia management

​Axsome Therapeutics has initiated the FORWARD Phase III trial evaluating AXS-14 for the management of fibromyalgia, with the first patient now dosed.

The post Axsome begins Phase III AXS-14 FORWARD trial for fibromyalgia management appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.